Cours Kane Biotech Inc Toronto S.E.
Actions
KNE
CA4838092084
Recherche biotechnologique et médicale
CA 2022 | 2,67 M 1,95 M 1,78 M | CA 2023 | 149 k 109 k 99,61 k | Capitalisation | 10,55 M 7,71 M 7,05 M |
---|---|---|---|---|---|
Résultat net 2022 | -3 M -2,19 M -2,01 M | Résultat net 2023 | -5 M -3,66 M -3,34 M | VE / CA 2022 | 6,37 x |
Dette nette 2022 | 5,76 M 4,21 M 3,85 M | Dette nette 2023 | 8,51 M 6,22 M 5,69 M | VE / CA 2023 | 128 x |
PER 2022 |
-2,79
x | PER 2023 |
-2,02
x | Employés | - |
Rendement 2022 * |
-
| Rendement 2023 |
-
| Flottant | 65,07% |
Dernier transcript sur Kane Biotech Inc
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Marc Edwards
CEO | Chief Executive Officer | - | 02/06/16 |
Ray Dupuis
DFI | Director of Finance/CFO | - | 05/09/17 |
Gregory Schultz
CTO | Chief Tech/Sci/R&D Officer | 73 | 05/04/22 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
R. Renaud
BRD | Director/Board Member | - | 15/09/10 |
Chairman | 59 | 20/02 | |
Georges Morin
BRD | Director/Board Member | - | 20/05/20 |
Varia. 1 janv. | Capi. | |
---|---|---|
+67,53% | 63,85 Md | |
-0,77% | 41,83 Md | |
+45,66% | 40,65 Md | |
-10,72% | 27,12 Md | |
+13,30% | 26,52 Md | |
-22,79% | 18,69 Md | |
+4,70% | 12,73 Md | |
+24,10% | 12,11 Md | |
+27,41% | 12,07 Md |